Triphasic waves in serotonin syndrome.
Dike
G L
GL
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000368:Aged; D000547:Amantadine / Q000009:adverse effects* / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D002230:Carbidopa / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D009207:Myoclonus / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline; D013577:Syndrome
D015057:1-Naphthylamine; D000547:Amantadine; D000978:Antiparkinson Agents; D002230:Carbidopa; D004338:Drug Combinations; D007980:Levodopa; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; C009265:carbidopa, levodopa drug combination